Corpus ID: 22102314

Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.

@article{Mohammad1998SuccessfulTO,
  title={Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.},
  author={R. Mohammad and M. Varterasian and V. P. Almatchy and G. N. Hannoudi and G. Pettit and A. Al-katib},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={1998},
  volume={4 5},
  pages={
          1337-43
        }
}
  • R. Mohammad, M. Varterasian, +3 authors A. Al-katib
  • Published 1998
  • Biology, Medicine
  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • We tested the activity of dolastatin 10 (a natural product derived from the shell-less marine mollusk, Dolabella auricularia, a sea hare) and its structural modification, auristatin PE, alone and in combination with bryostatin 1 (a protein kinase C activator derived from the marine bryozoan Bugula neritina) on a human B-cell chronic lymphocytic leukemia cell line (WSU-CLL) and in a severe combined immune deficient (SCID) mouse xenograft model bearing this cell line. WSU-CLL cells were cultured… CONTINUE READING
    45 Citations
    Pharmacology and clinical experience with bryostatin 1: a novel anticancer drug.
    • Philip, Zonder
    • Medicine
    • Expert opinion on investigational drugs
    • 1999
    • 27
    Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma.
    • 119
    Marine natural products: Bryostatins in preclinical and clinical studies
    • 58
    • Highly Influenced
    Bryostatin-1: A Novel PKC Inhibitor in Clinical Development
    • 136
    Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells.
    • 75
    Progress in the development and acquisition of anticancer agents from marine sources.
    • 131

    References

    SHOWING 1-10 OF 26 REFERENCES
    Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines.
    • 35
    Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells.
    • 120
    • PDF
    Modulation of drug-induced apoptosis by interruption of the protein kinase C signal transduction pathway: a new therapeutic strategy.
    • S. Grant, W. D. Jarvis
    • Biology, Medicine
    • Clinical cancer research : an official journal of the American Association for Cancer Research
    • 1996
    • 53
    • PDF